Evaluation of the effects of temporary covered nitinol stent placement in the prostatic urethra: Short-term study in the canine model

CardioVascular and Interventional Radiology

Volumn 30, Issue 4, 2007, Pages 731-737

  Crisóstomo, Verónica ^a   Song, Ho Young ^b   Maynar, Manuel ^a,c   Sun, Fei ^a   Soria, Federico ^a   Lima, Juan Rafael ^a   Yoon, Chang Jin ^d   Usón Gargallo, Jesús ^a  

^a JESÚS USÓN MINIMALLY INVASIVE SURGERY CENTRE   (Spain)

^b University of Ulsan College of Medicine   (South Korea)

^c UNIVERSITY OF LAS PALMAS DE GRAN CANARIA   (Spain)

^d Seoul National University Bundang Hospital   (South Korea)

Author keywords

Experimental study; Prostate stent; Retrievable stents

Indexed keywords

NITINOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOG; ENDOSCOPY; EUTHANASIA; EVALUATION; FIBROSIS; FOLLOW UP; NONHUMAN; PATHOLOGY; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; STENT; URETHROGRAPHY; URINE FLOW RATE;

ALLOYS; ANIMALS; ATROPHY; COATED MATERIALS, BIOCOMPATIBLE; DEVICE REMOVAL; DISEASE MODELS, ANIMAL; DOGS; FOREIGN-BODY REACTION; MALE; PROSTATE; PROSTATIC HYPERPLASIA; STENTS; URETHRA; URETHRAL OBSTRUCTION; URINARY BLADDER NECK OBSTRUCTION; URODYNAMICS;

EID: 36048946344     PISSN: 01741551     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00270-007-9006-9     Document Type: Article

References (28)

1. Berry SJ, Coffey DS, Walsh PC, et al. (1984) The development of human benign prostatic hyperplasia with age. J Urol 132:474-479
2. AUA Practice Guidelines Committee (2003) AUA Guideline on management of benign prostatic hyperplasia. Chapter 1: Diagnosis and treatment recommendations. J Urol 170:530-547
3. Ogiste JS, Cooper K, Kaplan SA (2003) Are stents still a useful therapy for benign prostatic hyperplasia? Curr Opin Urol 13:51-57
4. Masood S, Djaladat H, Kouriefs C, et al. (2004) The 12-year outcome analysis of an endourethral Wallstent for treating benign prostatic hyperplasia. Br J Urol Int 94:1271-1274
5. Fabian KM (1980) The intraprostatic "partial catheter" (urological spiral). Urologe A 19:236-238
6. Fitzpatrick JM, Mebust WK (2002) Minimally invasive and endoscopic management of benign prostatic hyperplasia. In: Walsh PC, Retik AB, Vaughan DE, Wein AJ (eds) Campbell's urology, 8th edn. WB Saunders, New York, pp 1380-1417
7. Oesterling JE, Defalco AJ, Kaplan SA, et al. (1994) The North American experience with the UroLume endoprothesis as a treatment for benign prostatic hyperplasia: Long-term results. Urology 44:353-362
8. Badlani GH, Press SM, Defalco A, et al. (1995) Urolume endourethral prosthesis for the treatment of urethral stricture disease: Long term results for the North American multicenter Urolume trial. Urology 45:846-856
9. Williams G, Coulane C, Milroy EJ, et al. (1993) The Urolume, a permanently implanted prostatic stent for patients at high risk for surgery: Result from 5 collaborative centres. Br J Urol 72:335-340
10. Guazzoni G, Montorsi F, Coulange C, et al. (1994) A modified prostatic Urolume Wallstent for healthy patients with symptomatic benign prostatic hyperplasia: A European multicenter study. Urology 44:364-370
11. Gesengerg A, Sintermann R (1998) Management of benign prostatic hyperplasia in high risk patients: Long term experience with the Memotherm stent. J Urol 160:72-76
12. Shah DK, Kapoor R, Badlani GH, et al. (2003) Experience with urethral stent explantation. J Urol 169:1398-1400
13. Wilson TS, Lemack GE, Dmochowski RR (2002) UroLume stents: Lessons learned. J Urol 167:2477-2480
14. De la Rossette JJ (2000) What we do and don't know about benign prostatic hyperplasia. Curr Opin Urol 10:1-2
15. Ko GY, Kim GC, Seo TS, et al. (2002) Covered, retrievable, expandable urethral nitinol stent: Feasibility study in dogs. Radiology 223:83-90
16. Song HY, Park H, Suh TS, et al. (2003) Recurrent traumatic urethral strictures near the external sphincter: Treatment with a covered, retrievable, expandable nitinol stent. Initial results. Radiology 226:433-440
17. Shin JH, Song HY, Park H, et al. (2006) Removal of retrievable self-expandable urethral stents: Experience in 58 stents. Eur Radiol 16:2037-2043
18. Guidelines for the care, use of laboratory animals (1996) Institute of Laboratory Animal Resources. Commission on Life Sciences. National Research Council. National Academy Press, Washington, DC
19. AVMA Panel on Euthanasia (2001) Report of the AVMA Panel on Euthanasia. J Am Vet Med Assoc 218:669-696
20. Gajewski JB, Chancellor MB, Ackman CF, et al. (2000) Removal of UroLume endoprosthesis: Experience of the North American Study Group for detrusor-sphincter dyssynergia application. J Urol 163:773-776
21. Anjum MI, Chari R, Shetty A, et al. (1997) Long-term clinical results and quality of life after insertion of a self-expanding flexible endourethral prosthesis. Br J Urol 80:885-888
22. Barber NK, Roodhouse AJ, Rathenborg P, et al. (2005) Ease of removal of thermo-expandable prostate stents. Br J Urol Int 96:578-580
23. Perry MJA, Roodhouse AJ, Gidlow AB, et al. (2002) Thermo-expandable intraprostatic stents in bladder outlet obstruction: An 8-year study. Br J Urol Int 90:216-223
24. Kapoor R, Liatsikos EN, Badlani G (2000) Endoprostatic stents for management of benign prostatic hyperplasia. Curr Opin Urol 10:19-22
25. Dobben RL, Wright KC, Dolenz D, et al. (1991) Prostatic urethra dilatation with the Gianturco self-expanding metallic stent: A feasibility study in cadaver specimens and dogs. AJR Am J Roentgenol 156:757-761
26. Bailey DM, Foley SJ, McFarlane JP, et al. (1998) Histological changes associated with long-term urethral stents. Br J Urol 81:745-749
27. Pomer S, Dobrowolski ZF (2002) The therapy of benign prostatic hyperplasia using less-invasive procedures: The current situation. Br J Urol Int 89:773-775
28. Djavan B, Fakhari M, Shariat S, et al. (1999) A novel intraurethral prostatic bridge catheter for prevention of temporary prostatic obstruction following high energy transurethral microwave thermotherapy in patients with benign prostatic hyperplasia. J Urol 161:144-151